Cited by 108Genomic variations and chromosomal abnormalitiesAutism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder.

Open access
van der Zwaag, Bert, Staal, Wouter G., Hochstenbach, Ron, Poot, Martin, Spierenburg, Henk A., de Jonge, Maretha V., Verbeek, Nienke E., van 't Slot, Ruben +9 more·2010·American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Abstract

High resolution genomic copy‐number analysis has shown that inherited and de novo copy‐number variations contribute significantly to autism pathology, and that identification of small chromosomal aberrations related to autism will expedite the discovery of risk genes involved. Here, we report a microduplication of chromosome 15q11.2, spanning only four genes, co‐segregating with autism in a Dutch pedigree, identified by SNP microarray analysis, and independently confirmed by FISH and MLPA analysis. Quantitative RT‐PCR analysis revealed over 70% increase in peripheral blood mRNA levels for the four genes present in the duplicated region in patients, and RNA in situ hybridization on mouse embryonic and adult brain sections revealed that two of the four genes, CYFIP1 and NIPA1 , were highly expressed in the developing mouse brain. These findings point towards a contribution of microduplications at chromosome 15q11.2 to autism, and highlight CYFIP1 and NIPA1 as autism risk genes functioning in axonogenesis and synaptogenesis. Thereby, these findings further implicate defects in dosage‐sensitive molecular control of neuronal connectivity in autism. However, the prevalence of this microduplication in patient samples was statistically not significantly different from control samples (0.94% in patients vs. 0.42% controls, P = 0.247), which suggests that our findings should be interpreted with caution and indicates the need for studies that include large numbers of control subjects to ascertain the impact of these changes on a population scale. © 2009 Wiley‐Liss, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajmg.b.31055

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Copy number variation at the 15q11.2 region is a significant risk locus for neurological and neuropsychiatric conditions such as schizophrenia and autism spectrum disorder.

    “Copy number variation (CNV) at the 15q11.2 region has been identified as a significant risk locus for neurological and neuropsychiatric conditions such as schizophrenia (SCZ) and autism spectrum disorder (ASD).”

    From The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines (2014) · cites this paper as [1]

    The indexed text reports a 15q11.2 microduplication co-segregating with autism in one family and describes the locus as a possible shared susceptibility region for ASD and schizophrenia. But it says the difference in duplication prevalence between ASD patients and controls was not statistically significant (p=0.247) and that its status as an autism risk factor remains under debate. It therefore does not establish 15q11.2 CNV as a significant risk locus for both conditions. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • CHRNA7 and CYFIP1 were already proposed as susceptibility genes for neuropsychiatric disorders, and our study provides additional support for this association.

    “CHRNA7 and CYFIP1 were already proposed as susceptibility genes for neuropsychiatric disorders [43], [45], [49], [51], and our study provides additional support for this association.”
  • The most compelling candidate in the deleted region is CYFIP1, which codes for a binding partner of FMRP, the protein responsible for fragile X syndrome.

    “However, the most compelling candidate in the deleted region is CYFIP1 [45], [53], which codes for a binding partner of FMRP, the protein responsible for fragile X syndrome.”
  • Dysregulation or mutations of FMRP-interacting proteins such as CYFIP1, eIF4E, and a subset of FMRP mRNA targets may contribute to the autism spectrum disorder phenotype observed in fragile X syndrome.

    “Recent evidence indicates that dysregulation and or mutations of FMRP-interacting proteins, such as the cytoplasmic FMRP-interacting protein 1 (CYFIP1) (52-55), eukaryotic initiation factor 4 (eIF4E) (56,57), and a subset of FMRP mRNA targets (58), may contribute to the ASD phenotype observed in FXS.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van der Zwaag, B., Staal, W. G., Hochstenbach, R., Poot, M., Spierenburg, H. A., de Jonge, M. V., Verbeek, N. E., van 't Slot, R., van Es, M. A., Staal, F. J., Freitag, C. M., Buizer‐Voskamp, J. E., Nelen, M. R., van den Berg, L. H., van Amstel, H. K. P., van Engeland, H., & Burbach, J. P. H.
Affiliations
  • University Medical Center Utrecht (NL)
  • Erasmus MC (NL)
  • Universitätsklinikum des Saarlandes (DE)
Corresponding author
Burbach, J. Peter H.
Venue
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Publisher
Wiley
Published
2010-05-17
Volume
153B
Issue
4
Pages
960-966
ISSN
  • 1552-4841 (ISSN-L)
  • 1552-485X
OpenAlex
W2081989700
Cited by
108
References
29
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 2 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 13 · 2013: 7 · 2012: 10
FWCI
4.46
Type
journal article
Language
en
Open access
Locations
  • American Journal of Medical Genetics Part B Neuropsychiatric Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Autism Speaks
  • Universiteit Utrecht
  • National Institutes of Health
  • National Institute of Mental Health (U24MH081810)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
autism spectrum disorder, microduplication, copy number variation, co-segregation, CYFIP1, NIPA1, autism risk genes, dosage-sensitive genes, axonogenesis, synaptogenesis, neuronal connectivity
MeSH terms
Animals, Autistic Disorder, Child, Child Development Disorders, Pervasive, Chromosome Aberrations, Chromosomes, Chromosomes, Human, Pair 2, Female, Genes, Humans, Nucleic Acid Hybridization, Risk, Case-Control Studies, Reverse Transcriptase Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review